DK2468292T3 - Nyt peptid med antisekretorisk aktivitet - Google Patents

Nyt peptid med antisekretorisk aktivitet Download PDF

Info

Publication number
DK2468292T3
DK2468292T3 DK12157100.4T DK12157100T DK2468292T3 DK 2468292 T3 DK2468292 T3 DK 2468292T3 DK 12157100 T DK12157100 T DK 12157100T DK 2468292 T3 DK2468292 T3 DK 2468292T3
Authority
DK
Denmark
Prior art keywords
new peptide
antisecretory activity
antisecretory
activity
peptide
Prior art date
Application number
DK12157100.4T
Other languages
English (en)
Inventor
Stefan Lange
Eva Jennische
Hans-Arne Hansson
Original Assignee
Lantmaennen Medical Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lantmaennen Medical Ab filed Critical Lantmaennen Medical Ab
Application granted granted Critical
Publication of DK2468292T3 publication Critical patent/DK2468292T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
DK12157100.4T 2006-04-27 2007-04-27 Nyt peptid med antisekretorisk aktivitet DK2468292T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0600932 2006-04-27
EP07748079.6A EP2015767B1 (en) 2006-04-27 2007-04-27 Use of antisecretory factor for treating intraocular hypertension

Publications (1)

Publication Number Publication Date
DK2468292T3 true DK2468292T3 (da) 2020-03-23

Family

ID=38561776

Family Applications (2)

Application Number Title Priority Date Filing Date
DK12157100.4T DK2468292T3 (da) 2006-04-27 2007-04-27 Nyt peptid med antisekretorisk aktivitet
DK07748079.6T DK2015767T3 (da) 2006-04-27 2007-04-27 Anvendelse af antisekretorisk faktor til behandling af intraokulær hypertension

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK07748079.6T DK2015767T3 (da) 2006-04-27 2007-04-27 Anvendelse af antisekretorisk faktor til behandling af intraokulær hypertension

Country Status (18)

Country Link
US (2) US8207296B2 (da)
EP (2) EP2015767B1 (da)
JP (2) JP5284948B2 (da)
KR (1) KR20090040404A (da)
CN (2) CN101432013B (da)
AU (1) AU2007244004B2 (da)
BR (1) BRPI0710959B8 (da)
CA (2) CA2771087C (da)
DK (2) DK2468292T3 (da)
ES (2) ES2561945T3 (da)
IL (1) IL194773A (da)
MX (1) MX2008013769A (da)
NZ (2) NZ598426A (da)
PL (2) PL2015767T3 (da)
RU (1) RU2458703C2 (da)
SG (1) SG171602A1 (da)
WO (1) WO2007126364A2 (da)
ZA (1) ZA200809115B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2561945T3 (es) * 2006-04-27 2016-03-01 Lantmannen As-Faktor Ab Uso de un factor antisecretor para tratar la hipertensión intraocular
US9962424B2 (en) 2007-04-27 2018-05-08 Lantmännen As-Faktor Ab Use of antisecretory factors (AF) for optimizing cellular uptake
JP5820277B2 (ja) 2009-02-11 2015-11-24 ラントメネン・アーエス−ファクトール・アーベー 細胞取込を最適化するための抗分泌性因子(af)の使用
WO2013050795A1 (en) * 2011-10-03 2013-04-11 Femtonics Kft. Use of photoactive compounds
EP2934564B1 (en) * 2012-12-20 2018-05-23 Lantmännen AS-Faktor AB Antisecretory factor (af) for use in the treatment of glioblastoma
RU2723097C1 (ru) 2015-07-10 2020-06-08 Лантменнен Ас-Фактор Аб Способ получения яичного желтка с высоким содержанием af-16
EP3484909B1 (en) 2016-07-18 2021-06-16 Lantmännen Medical AB Antisecretory factor 17
CA3103164A1 (en) 2018-06-28 2020-01-02 Lantmannen Medical Ab Antisecretory factor for use in treatment and/or prevention of acute respiratory failure
WO2020065089A2 (en) 2018-09-28 2020-04-02 Lantmännen Functional Foods Ab A consumable product comprising malted dehulled oat
WO2020065091A1 (en) 2018-09-28 2020-04-02 Lantmännen Functional Foods Ab A consumable product comprising malted wheat
WO2021191431A1 (en) 2020-03-26 2021-09-30 Lantmännen Functional Foods Ab A consumable product comprising malted cereals for promoting recovery at physical activity
WO2024102346A1 (en) * 2022-11-08 2024-05-16 Aisa Pharma, Inc. Methods of treating eye pain and eye disorders

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH682716A5 (de) 1992-01-13 1993-11-15 Christian Fricker Benzo-Pyrone und/oder Dobesilat-Calcium enthaltende pharmazeutische Zusammensetzung.
US5585401A (en) * 1994-12-09 1996-12-17 The Reents Of The University Of California Method for enhancing outflow of aqueous humor in treatment of glaucoma
SE508609C2 (sv) 1995-08-24 1998-10-19 Rural Patent Svenska Ab Antisekretorisk faktor - dess aminosyrasekvens, nubleinsyrasekvens och användning
JP2000506375A (ja) * 1996-01-26 2000-05-30 エイチエスシー リサーチ アンド デベロップメント リミテッド パートナーシップ アルツハイマー病に関連する核酸およびタンパク質、ならびにその使用
SE506486C2 (sv) * 1996-11-20 1997-12-22 Svenska Lantmaennen Riksfoerbu Födoämne som vid förtäring inducerar antisekretoriska proteiner
SE513496C2 (sv) * 1998-12-17 2000-09-18 Rural Patent Svenska Ab NASP-berikad äggula samt dess användning
JP2004513066A (ja) * 1999-06-21 2004-04-30 インカイン ファーマシューティカル カンパニー,インコーポレイティド アンジオシジン:cys−ser−val−thr−cys−gly特異的腫瘍細胞付着受容体
RU2192898C1 (ru) * 2001-08-16 2002-11-20 Московский научно-исследовательский институт глазных болезней им. Гельмгольца Способ лечения герпетического кератита с изъязвлением
GB0322645D0 (en) * 2003-09-26 2003-10-29 Melacure Therapeutics Ab Use of antisecretory factor peptides
ES2561945T3 (es) * 2006-04-27 2016-03-01 Lantmannen As-Faktor Ab Uso de un factor antisecretor para tratar la hipertensión intraocular
CA2650132C (en) * 2006-04-27 2017-10-24 Hans-Arne Hansson Modulation of lipid rafts
DK2037950T3 (da) * 2006-04-27 2014-06-30 Lantmännen As Faktor Ab Yderligere medicinske anvendelser af antisekretorisk protein

Also Published As

Publication number Publication date
US20120283191A1 (en) 2012-11-08
ES2561945T3 (es) 2016-03-01
BRPI0710959A2 (pt) 2012-02-28
CA2650344C (en) 2017-10-31
KR20090040404A (ko) 2009-04-24
JP5284948B2 (ja) 2013-09-11
RU2458703C2 (ru) 2012-08-20
CA2650344A1 (en) 2007-11-08
IL194773A (en) 2015-07-30
BRPI0710959B8 (pt) 2021-05-25
EP2468292A1 (en) 2012-06-27
EP2468292B1 (en) 2019-12-18
US20090162296A1 (en) 2009-06-25
US9000125B2 (en) 2015-04-07
IL194773A0 (en) 2011-08-01
BRPI0710959B1 (pt) 2018-11-06
DK2015767T3 (da) 2016-02-08
EP2015767B1 (en) 2016-01-06
NZ598426A (en) 2012-08-31
PL2015767T3 (pl) 2016-05-31
WO2007126364A8 (en) 2009-07-23
WO2007126364A2 (en) 2007-11-08
WO2007126364A3 (en) 2008-03-06
RU2008146733A (ru) 2010-06-10
CA2771087A1 (en) 2007-11-08
EP2015767A2 (en) 2009-01-21
EP2468292B8 (en) 2020-02-26
JP2012153695A (ja) 2012-08-16
AU2007244004A1 (en) 2007-11-08
CN101432013A (zh) 2009-05-13
NZ572255A (en) 2012-03-30
CN102633863A (zh) 2012-08-15
CA2771087C (en) 2016-03-15
US8207296B2 (en) 2012-06-26
CN101432013B (zh) 2015-01-07
MX2008013769A (es) 2009-02-03
ES2773945T3 (es) 2020-07-15
AU2007244004B2 (en) 2012-02-09
JP2009535329A (ja) 2009-10-01
SG171602A1 (en) 2011-06-29
PL2468292T3 (pl) 2020-08-24
ZA200809115B (en) 2009-07-29
CN102633863B (zh) 2014-08-06

Similar Documents

Publication Publication Date Title
DK2468292T3 (da) Nyt peptid med antisekretorisk aktivitet
BRPI0813942A2 (pt) Polipeptídio ace2
DK2171053T3 (da) Natriuretiske polypeptider
DE602005000208D1 (de) Kraftstoffzufuhrsystem
DK1661627T3 (da) Dyseanordning
DE602005015131D1 (de) Interleukin-15-antagonistisches peptid
DK2064228T3 (da) Syntetiske peptidamider
DK2035447T3 (da) Polypeptid
DK2602263T3 (da) Polypeptider omfattende en isbindende aktivitet
DK2035451T3 (da) Insulinoptrop peptidsyntese
BRPI0911743A2 (pt) "peptídeo"
FR2910401B1 (fr) Appui-tete escamotable
ITMI20041573A1 (it) Fluoroelastomeri
DE602006006605D1 (de) Einspritzleitung
DK2402364T3 (da) Et nonapeptid med anti-tumor aktivitet
DE602005002290D1 (de) Kraftstoffschlauch
DK1968623T3 (da) Bacteriocin-inducer-peptider
DE502006004022D1 (de) Einspritzdüse
ITMI20060083A1 (it) Fluoroelastomeri
ITTO20050022A1 (it) Impianto di alimentazione del carburante
FR2910406B1 (fr) Appui-tete escamotable
DK2195435T3 (da) Trichoderma-promoter
DE502008002789D1 (de) Hochdruckreinigungsgerät
DK2049092T3 (da) Præparater med forbedret elastiserende aktivitet
FI20075483A0 (fi) Uusi peptidi